Your browser doesn't support javascript.
loading
Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results.
Auner, Holger W; Brown, Sarah R; Walker, Katrina; Kendall, Jessica; Dawkins, Bryony; Meads, David; Morgan, Gareth J; Kaiser, Martin F; Cook, Mark; Roberts, Sadie; Parrish, Christopher; Cook, Gordon.
Afiliação
  • Auner HW; Department of Immunology and Inflammation and The Hugh and Josseline Langmuir Centre for Myeloma Research, Imperial College London, London, UK.
  • Brown SR; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Walker K; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Kendall J; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Dawkins B; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
  • Meads D; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
  • Morgan GJ; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
  • Kaiser MF; The Institute of Cancer Research, London, UK.
  • Cook M; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Roberts S; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK.
  • Parrish C; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Cook G; Department of Clinical Haematology, St. James's University Hospital, Leeds, UK.
Blood Cancer J ; 12(4): 52, 2022 04 01.
Article em En | MEDLINE | ID: mdl-35365598

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Aged / Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Aged / Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos